CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION

In this paper we thought to investigate clinical value of tissue inhibitor of metalloproteinase-1 (TIMP-1) in predicting left ventricular (LV) myocardial remodeling in patients having Q-wave myocardial infarction (Q-wave MI). We demonstrated that TIMP-1 serum level clearly corresponds to degree of p...

Full description

Bibliographic Details
Main Authors: A. S. Vorobyev, L. V. Kovalenko, K. Yu. Nikolaev, I. A. Urvantseva, T. О. Simonyan, М. I. Rudenko
Format: Article
Language:Russian
Published: Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics 2019-06-01
Series:Атеросклероз
Subjects:
Online Access:https://ateroskleroz.elpub.ru/jour/article/view/131/331
_version_ 1797966012616802304
author A. S. Vorobyev
L. V. Kovalenko
K. Yu. Nikolaev
I. A. Urvantseva
T. О. Simonyan
М. I. Rudenko
author_facet A. S. Vorobyev
L. V. Kovalenko
K. Yu. Nikolaev
I. A. Urvantseva
T. О. Simonyan
М. I. Rudenko
author_sort A. S. Vorobyev
collection DOAJ
description In this paper we thought to investigate clinical value of tissue inhibitor of metalloproteinase-1 (TIMP-1) in predicting left ventricular (LV) myocardial remodeling in patients having Q-wave myocardial infarction (Q-wave MI). We demonstrated that TIMP-1 serum level clearly corresponds to degree of postinfarction LV myocardial remodeling. In patients who had serum concentrations of TIMP-1 over the established cut-off value (144.0 ng/ml), the risk of post-infarction LV remodeling was 3.33 times higher than in individuals who had TIMP-1 levels lower this value. Thus, TIMP-1 is a reliable prediction biomarker of adverse left ventricular myocardial remodeling in Q-wave MI.
first_indexed 2024-04-11T02:07:57Z
format Article
id doaj.art-f7368b1c6e5d4a43b42f04967dc16759
institution Directory Open Access Journal
issn 2078-256X
language Russian
last_indexed 2024-04-11T02:07:57Z
publishDate 2019-06-01
publisher Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
record_format Article
series Атеросклероз
spelling doaj.art-f7368b1c6e5d4a43b42f04967dc167592023-01-03T02:44:13ZrusSiberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and GeneticsАтеросклероз2078-256X2019-06-011521723https://doi.org/10.15372/ATER20190203CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTIONA. S. Vorobyev0L. V. Kovalenko1K. Yu. Nikolaev2I. A. Urvantseva3T. О. Simonyan4М. I. Rudenko5Surgut State University; District Cardiology Clinic Center of Diagnostics and Cardiovascular Surgery Russian FederationSurgut State University Russian FederationSurgut State University; Research Institute of Internal and Preventive Medicine – Branch of Federal Research Institute of Cytology and Genetics of SB RAS Russian FederationSurgut State University; District Cardiology Clinic Center of Diagnostics and Cardiovascular Surgery Russian FederationSurgut State University Russian FederationSurgut State University Russian FederationIn this paper we thought to investigate clinical value of tissue inhibitor of metalloproteinase-1 (TIMP-1) in predicting left ventricular (LV) myocardial remodeling in patients having Q-wave myocardial infarction (Q-wave MI). We demonstrated that TIMP-1 serum level clearly corresponds to degree of postinfarction LV myocardial remodeling. In patients who had serum concentrations of TIMP-1 over the established cut-off value (144.0 ng/ml), the risk of post-infarction LV remodeling was 3.33 times higher than in individuals who had TIMP-1 levels lower this value. Thus, TIMP-1 is a reliable prediction biomarker of adverse left ventricular myocardial remodeling in Q-wave MI.https://ateroskleroz.elpub.ru/jour/article/view/131/331myocardial infarctionmyocardial remodelingtimp-1prediction.
spellingShingle A. S. Vorobyev
L. V. Kovalenko
K. Yu. Nikolaev
I. A. Urvantseva
T. О. Simonyan
М. I. Rudenko
CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
Атеросклероз
myocardial infarction
myocardial remodeling
timp-1
prediction.
title CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
title_full CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
title_fullStr CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
title_full_unstemmed CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
title_short CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
title_sort clinical predictive value of tissue inhibitor of metalloproteinase 1 imyocardial remodeling development in patients having q wave myocardial infarction
topic myocardial infarction
myocardial remodeling
timp-1
prediction.
url https://ateroskleroz.elpub.ru/jour/article/view/131/331
work_keys_str_mv AT asvorobyev clinicalpredictivevalueoftissueinhibitorofmetalloproteinase1imyocardialremodelingdevelopmentinpatientshavingqwavemyocardialinfarction
AT lvkovalenko clinicalpredictivevalueoftissueinhibitorofmetalloproteinase1imyocardialremodelingdevelopmentinpatientshavingqwavemyocardialinfarction
AT kyunikolaev clinicalpredictivevalueoftissueinhibitorofmetalloproteinase1imyocardialremodelingdevelopmentinpatientshavingqwavemyocardialinfarction
AT iaurvantseva clinicalpredictivevalueoftissueinhibitorofmetalloproteinase1imyocardialremodelingdevelopmentinpatientshavingqwavemyocardialinfarction
AT tosimonyan clinicalpredictivevalueoftissueinhibitorofmetalloproteinase1imyocardialremodelingdevelopmentinpatientshavingqwavemyocardialinfarction
AT mirudenko clinicalpredictivevalueoftissueinhibitorofmetalloproteinase1imyocardialremodelingdevelopmentinpatientshavingqwavemyocardialinfarction